Welcome to our dedicated page for QUANTASING GROUP SEC filings (Ticker: QSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QuantaSing Group Limited, now operating as Here Group Limited, files as a foreign private issuer using Form 20-F and Form 6-K reports. The filings document the company's transition to an IP-based pop toy company, Nasdaq name and ticker changes, ADS-related voting materials, and shareholder approvals from extraordinary general meeting materials.
Regulatory disclosures also cover unaudited financial results, annual report availability, capital-structure matters, and material reports tied to the company's Letsvan investment and pop toy operations. The record includes notices, proxy forms, depositary materials, and current reports that describe governance actions, shareholder voting mechanics, and foreign-issuer reporting obligations.
Form 144 filing overview: On 26 June 2025, DCM VIII LP, an investment fund affiliated with a QuantaSing Group Ltd. (NASDAQ:QSG) director, filed a Form 144 indicating its intention to sell up to 8,123 American Depositary Receipts (ADRs). At the price disclosed in the filing, the proposed sale is valued at approximately US$70,140.
Scale of planned sale: The 8,123 ADRs represent roughly 0.0026 % of the company’s 311.3 million shares outstanding, implying negligible dilution or ownership impact. Morgan Stanley Smith Barney LLC will execute the trade, with the transaction targeted for 26 June 2025 on Nasdaq.
Recent insider activity: Related DCM entities sold an aggregate 79,332 ADRs over the prior three months, generating gross proceeds of about US$730,370. Even collectively, these disposals equal only ~0.025 % of shares outstanding, suggesting limited market pressure.
Acquisition background: The securities were originally obtained via a private purchase from the issuer on 23 April 2018 for cash. The filer certified that it holds no undisclosed material adverse information about QuantaSing. The notice was signed by Andre Levi.
Key takeaway: The filing is an administrative notice of a relatively small insider sale; it contains no operational or financial data and does not materially alter the investment thesis on QSG.
QuantaSing Group Ltd. (QSG) – Form 144 filing dated 26 Jun 2025 details a proposed insider sale under Rule 144.
- Seller: DCM Affiliates Fund VIII, LP, identified as a Director-related holder.
- Proposed sale: 2,420 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney LLC on or about 26 Jun 2025.
- Market value: US $20,896.22 (≈ $8.63 per ADR).
- Share base: 311,328,381 ADRs outstanding; the proposed sale equals ≈0.0008 % of shares outstanding—an immaterial fraction.
- Recent activity: The same fund complex disposed of 79,332 ADRs over the previous day (25 Jun 2025) for gross proceeds of US $730,370.06.
- Acquisition history: The securities were originally acquired in a private transaction on 23 Apr 2018 for cash.
The filing affirms that the seller possesses no undisclosed material adverse information and has signed under penalty of Rule 144 and 18 U.S.C. 1001. No additional financial metrics, earnings data, or strategic developments are provided.
Investor takeaway: While insider selling can signal negative sentiment, the volume (<1 bps of float) and dollar amount are de minimis; therefore, the filing is unlikely to affect market valuation materially. It mainly reflects routine liquidity management by a venture-capital affiliate.
QuantaSing Group Limited (QSG) has filed a Form 144 with the SEC, signaling the proposed sale of 1,765 American Depositary Shares (ADRs) on or about 25 June 2025 through Morgan Stanley Smith Barney on Nasdaq. The aggregate market value of the planned sale is US$16,249.47, versus a total of 311,328,381 shares outstanding, implying a dilution of less than 0.001%.
The seller originally acquired the ADRs in April 2018 via a private, cash-settled transaction with the issuer. No other sales have been reported in the past three months. Form 144 requires the filer to affirm that no undisclosed material adverse information exists. Given the modest size of the transaction relative to the company’s float, the filing appears routine and is unlikely to affect market dynamics.
QuantaSing Group Limited (QSG) filed a Form 144 signaling an intent to sell up to 5,926 American Depositary Receipts (ADRs) through Morgan Stanley Smith Barney on or about 06/25/2025.
The proposed sale carries an aggregate market value of $54,557.72, equating to roughly 0.0019 % of the company’s 311,328,381 shares outstanding. The shares were originally acquired on 04/23/2018 via a private purchase from the issuer for cash. No other sales by this holder have occurred during the past three months.
Given the very small size relative to QuantaSing’s float, the notice appears immaterial to valuation or liquidity and is largely a routine compliance disclosure under Rule 144.